Mural Oncology plc

NASDAQ:MURA

3.29

+0.14 (+4.44%)

Mural Oncology plc Stock, NASDAQ:MURA

10 Earlsfort Terrace, Dublin, Dublin 2

Ireland

Phone: +353.1.905.8020

Number of Employees: 117

http://www.muraloncology.com

Description

Mural Oncology Plc is a clinical-stage oncology company, which engages in the business of discovering and developing immunotherapies for patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.